Unique considerations when managing hypertension in the transplant patient

Donald Mitema, Carrie Schinstock

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages341-353
Number of pages13
DOIs
StatePublished - Jan 1 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume956
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Transplants
Transplantation (surgical)
Hypertension
Organ Transplantation
Gift Giving
Epidemiology
Population
Health
Morbidity
Kidney
Mortality
Transplant Recipients

Keywords

  • Blood pressure in solid organ transplant recipients
  • Calcineurin inhibitors
  • Hypertension
  • Post-transplant hypertension

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mitema, D., & Schinstock, C. (2017). Unique considerations when managing hypertension in the transplant patient. In Advances in Experimental Medicine and Biology (pp. 341-353). (Advances in Experimental Medicine and Biology; Vol. 956). Springer New York LLC. https://doi.org/10.1007/5584_2016_87

Unique considerations when managing hypertension in the transplant patient. / Mitema, Donald; Schinstock, Carrie.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2017. p. 341-353 (Advances in Experimental Medicine and Biology; Vol. 956).

Research output: Chapter in Book/Report/Conference proceedingChapter

Mitema, D & Schinstock, C 2017, Unique considerations when managing hypertension in the transplant patient. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 956, Springer New York LLC, pp. 341-353. https://doi.org/10.1007/5584_2016_87
Mitema D, Schinstock C. Unique considerations when managing hypertension in the transplant patient. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2017. p. 341-353. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/5584_2016_87
Mitema, Donald ; Schinstock, Carrie. / Unique considerations when managing hypertension in the transplant patient. Advances in Experimental Medicine and Biology. Springer New York LLC, 2017. pp. 341-353 (Advances in Experimental Medicine and Biology).
@inbook{f5a243c5e9794479b707aec0660152d5,
title = "Unique considerations when managing hypertension in the transplant patient",
abstract = "For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.",
keywords = "Blood pressure in solid organ transplant recipients, Calcineurin inhibitors, Hypertension, Post-transplant hypertension",
author = "Donald Mitema and Carrie Schinstock",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/5584_2016_87",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "341--353",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Unique considerations when managing hypertension in the transplant patient

AU - Mitema, Donald

AU - Schinstock, Carrie

PY - 2017/1/1

Y1 - 2017/1/1

N2 - For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.

AB - For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.

KW - Blood pressure in solid organ transplant recipients

KW - Calcineurin inhibitors

KW - Hypertension

KW - Post-transplant hypertension

UR - http://www.scopus.com/inward/record.url?scp=85019255474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019255474&partnerID=8YFLogxK

U2 - 10.1007/5584_2016_87

DO - 10.1007/5584_2016_87

M3 - Chapter

C2 - 27815930

AN - SCOPUS:85019255474

T3 - Advances in Experimental Medicine and Biology

SP - 341

EP - 353

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -